The expression levels of Atg5 were not significantly different among any of the groups, and the levels of Hspa5 were upregulated in the amyloidosis-induced group without CR treatment (AL+F) but repressed by CR treatment (CR+F). The gene discussed is HSPA5; the disease is amyloidosis.